N van Rooijen Selected Research

N van Rooijen Research Topics

Disease

7	Infections 01/2014 - 01/2000
3	Pneumonia (Pneumonitis) 01/2014 - 05/2001
3	Inflammation (Inflammations) 08/2008 - 02/2001
2	Neoplasms (Cancer) 05/2011 - 07/2009
2	Glioma (Gliomas) 05/2011 - 07/2009
2	Necrosis 03/2001 - 12/2000
2	Hyperalgesia 11/2000 - 05/2000
1	Celiac Disease (Celiac Sprue) 01/2017
1	Type 2 von Willebrand Disease 05/2015
1	Human Influenza (Influenza) 01/2014
1	Viral Pneumonia 01/2014
1	Hyperplasia 01/2014
1	Neoplasm Metastasis (Metastasis) 10/2013
1	Pancreatic Neoplasms (Pancreatic Cancer) 09/2013
1	Foot-and-Mouth Disease 11/2011
1	Lymphoma (Lymphomas) 01/2009
1	Lung Injury 08/2008
1	Ocular Hypertension (Glaucoma, Suspect) 04/2008
1	Osteophyte 01/2004
1	Hepatitis 04/2001
1	Tuberculosis (Tuberculoses) 04/2001
1	Pulmonary Tuberculosis 04/2001
1	Immune System Diseases (Immune Disorders) 03/2001
1	Asthma (Bronchial Asthma) 02/2001
1	Parasitemia 12/2000
1	Vesicular Stomatitis 12/2000
1	Fibrosis (Cirrhosis) 12/2000
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 12/2000
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 10/2000
1	Autoimmune Diseases (Autoimmune Disease) 10/2000
1	Synovitis 09/2000
1	Rheumatoid Arthritis 09/2000
1	Body Weight (Weight, Body) 08/2000
1	Escherichia coli Infections 06/2000
1	Virus Diseases (Viral Diseases) 05/2000
1	Wallerian Degeneration 05/2000
1	Keratitis 01/2000
1	Hematuria 01/2000

Drug/Important Bio-Agent (IBA)

12	Liposomes (Liposome)IBA 10/2013 - 01/2000
7	Clodronic Acid (Clodronate)IBA 08/2008 - 05/2000
4	CytokinesIBA 02/2001 - 02/2000
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2001 - 12/2000
3	LE-Cl2MDPIBA 04/2001 - 08/2000
2	Matrix Metalloproteinase 14 (MT1-MMP)IBA 05/2011 - 07/2009
2	Metalloproteases (Metalloproteinases)IBA 05/2011 - 07/2009
2	Proteins (Proteins, Gene)FDA Link 07/2009 - 08/2008
2	Fas Ligand Protein (Fas Ligand)IBA 08/2008 - 04/2001
2	LipopolysaccharidesIBA 03/2001 - 01/2001
2	EndotoxinsIBA 01/2001 - 01/2000
1	Dietary ProteinsIBA 01/2017
1	GliadinIBA 01/2017
1	von Willebrand FactorIBA 05/2015
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 01/2014
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 01/2014
1	Antiviral Agents (Antivirals)IBA 01/2014
1	Surface-Active Agents (Surfactants)IBA 01/2014
1	Messenger RNA (mRNA)IBA 01/2014
1	Protein CIBA 01/2014
1	Oseltamivir (Tamiflu)FDA Link 01/2014
1	Inactivated VaccinesIBA 11/2011
1	AntibodiesIBA 11/2011
1	VaccinesIBA 11/2011
1	Conditioned Culture MediaIBA 05/2011
1	Drinking WaterIBA 05/2011
1	Anti-Bacterial Agents (Antibiotics)IBA 05/2011
1	Minocycline (Cyclops)FDA LinkGeneric 05/2011
1	p38 Mitogen-Activated Protein KinasesIBA 07/2009
1	Toll-Like Receptors (Toll-Like Receptor)IBA 07/2009
1	progelatinaseIBA 07/2009
1	dacetuzumabIBA 01/2009
1	Caspase 3 (Caspase-3)IBA 08/2008
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 04/2008
1	Transforming Growth Factor beta (TGF-beta)IBA 01/2004
1	Interleukin-10 (Interleukin 10)IBA 05/2001
1	Recombinases (Recombinase)IBA 04/2001
1	Interleukin-4 (Interleukin 4)IBA 04/2001
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 04/2001
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 04/2001
1	Intravenous Immunoglobulins (IVIG)FDA Link 03/2001
1	CorticosteroneIBA 03/2001
1	Interleukin-1beta (Interleukin 1 beta)IBA 03/2001
1	AllergensIBA 02/2001
1	Chloroquine (Aralen)FDA LinkGeneric 12/2000
1	ChemokinesIBA 12/2000
1	HaptensIBA 12/2000
1	AcidsIBA 12/2000
1	semapimodIBA 11/2000
1	salicylhydroxamic acid (SHAM)IBA 11/2000
1	AutoantibodiesIBA 10/2000
1	Immunoglobulins (Immunoglobulin)IBA 10/2000
1	Inosine Triphosphate (ITP)IBA 10/2000
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 09/2000
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 09/2000
1	Heparin (Liquaemin)FDA LinkGeneric 01/2000

Therapy/Procedure

3	Therapeutics 01/2014 - 05/2011
2	Injections 01/2004 - 01/2000
2	Intranasal Administration 05/2001 - 04/2001
1	Intraventricular Injections 10/2001
1	Transplantation 08/2000
1	Intravenous Injections 05/2000